Camlin Fine Sciences Ltd Annually Results

Gross Sales

1,666.53

1,453.91

1,681.56

1,412.09

1,187.1

Excise Duty

0

0

0

0

0

Net Sales

1,666.53

1,453.91

1,681.56

1,412.09

1,187.1

Other Operating Income

0

0

0

0

0

Other Income

14.89

15.55

5.8

33.03

4.98

Total Income

1,681.42

1,469.46

1,687.36

1,445.12

1,192.09

Total Expenditure

1,675.75

1,452.03

1,485.97

1,259.41

1,005.17

PBIDT

5.67

17.42

201.39

185.71

186.92

Interest

99.88

60.3

58.5

35.77

37.53

PBDT

-94.21

-42.88

142.89

149.94

149.39

Depreciation

63.84

56.36

62.51

55.96

44.29

Minority Interest Before NP

0

0

0

0

0

Tax

42.13

24.87

28.68

32.07

27.36

Deferred Tax

-42.06

-19.24

11.89

1.53

12.38

Reported Profit After Tax

-158.12

-104.88

39.81

60.37

65.36

Minority Interest After NP

-19.07

-12.12

-12.3

-0.31

14.39

Net Profit after Minority Interest

-139.05

-92.75

52.11

60.68

50.96

Extra-ordinary Items

-208.98

-157.83

-4.79

0

0

Adjusted Profit After Extra-ordinary item

69.93

65.08

56.9

60.68

50.96

EPS (Unit Curr.)

2.89

-5.58

3.45

4.65

4.13

Book Value (Unit Curr.)

0

0

0

0

0

Dividend (%)

0

0

0

0

0

Equity

18.79

16.75

15.71

15.7

12.75

Public Shareholding (Number)

0

0

0

0

0

Public Shareholding (%)

0

0

0

0

0

Pledged/Encumbered - No. of Shares

0

0

0

0

0

Pledged/Encumbered - % in Total Promoters Holding

0

0

0

0

0

Pledged/Encumbered - % in Total Equity

0

0

0

0

0

Non Encumbered - No. of Shares

0

0

0

0

0

Non Encumbered - % in Total Promoters Holding

0

0

0

0

0

Non Encumbered - % in Total Equity

0

0

0

0

0

PBIDTM(%)

0.34

1.19

11.97

13.15

15.74

PBDTM(%)

-5.65

-2.94

8.49

10.61

12.58

PATM(%)

-9.48

-7.21

2.36

4.27

5.5